Literature DB >> 10830338

Psychological adjustment to success and to failure following epilepsy surgery.

P A Derry1, S Wiebe.   

Abstract

Treatment-refractory epilepsy can directly impair psychological adjustment and quality of life. Epilepsy surgery is viewed by the patient as a stressful life event, arrived at after extensive deliberation. It is accompanied by expectations and anxiety for patients and their families. We suggest that the success of epilepsy surgery (as reflected by patient-perceived impact on quality of life) depends not only on reduced seizure frequency, but on personality factors and psychosocial issues. This paper reviews our research on these factors, along with suggestions for psychological assessment (of quality of life, and of personality) and psychological treatment. Studies of quality of life in patients undergoing temporal lobectomy are also examined. Finally, factors leading to the perception of "failed" epilepsy surgery are considered, along with suggested ways to manage such cases.

Entities:  

Mesh:

Year:  2000        PMID: 10830338     DOI: 10.1017/s0317167100000779

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  3 in total

1.  The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK.

Authors:  Agnes Benedict; Lara Verdian; Grant Maclaine
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Influence of personality profile in patients with drug-resistant epilepsy on quality of life following surgical treatment: A 1-year follow-up study.

Authors:  Elena Iurina; Eva Bailles; Mar Carreño; Antonio Donaire; Jordi Rumià; Teresa Boget; Núria Bargalló; Xavier Setoain; Pedro Roldan; Estefanía Conde-Blanco; María Centeno; Luis Pintor
Journal:  Personal Ment Health       Date:  2022-08-22

Review 3.  Rates and predictors of success and failure in repeat epilepsy surgery: A meta-analysis and systematic review.

Authors:  Max O Krucoff; Alvin Y Chan; Stephen C Harward; Shervin Rahimpour; John D Rolston; Carrie Muh; Dario J Englot
Journal:  Epilepsia       Date:  2017-10-10       Impact factor: 5.864

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.